CClinicalTrials.gg
Not yet recruitingNCT06566365Updated Nov 14, 2024

Effect of Hormonal Cahanges During Menstrual Cycle on Subcostal Transversus Abdominis Plane Block

An interventional study of Subcostal Transversus Abdominis Plane Block in Menstrual Cycle and Subcostal Transversus Abdominis Plane Block, sponsored by Adiyaman University Research Hospital. Not yet recruiting at 1 site in Turkey. Open to female participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-11-14.

Sponsored by Adiyaman University Research Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 9 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
Female
01

Study summary

Fascial plane blocks are traditionally considered regional anesthesia techniques, where a mixture of local anesthetic (LA) is injected into a plane between two fascial layers, with the aim of spreading along this anatomical plane to block the nerves lying within or passing through it . Various pathophysiological processes that alter the structure and characteristics of fasciae can affect the spread of the local anesthetic and the success of the block. Diabetes, hormonal changes, and cannabinoid use are among these factors. This study aims to investigate the effects of hormonal changes during the menstrual cycle on subcostal TAP block.

Read the detailed description

Female patients scheduled for laparoscopic cholecystectomy at Adıyaman University Training and Research Hospital, who have been informed about the study and have provided written consent to participate, will be included in the study. The patients who agree to participate will be divided into groups based on the phases of their menstrual cycles. After ensuring airway safety under general anesthesia, a bilateral TAP block using 20 cc of 0.25% bupivacaine with a subcostal approach under ultrasound guidance will be administered to both groups. The study aims to compare the hemodynamic values (arterial blood pressure, heart rate, peripheral oxygen saturation) during the perioperative period, the visual analog scale (VAS) scores postoperatively, and the Quality of Recovery-15 (QoR-15) scores at 24 hours postoperatively between the two groups. This will allow for the investigation of the effects of hormonal changes during the menstrual cycle on the efficacy and success of subcostal TAP blocks.

02

Conditions studied

  • Menstrual Cycle
  • Subcostal Transversus Abdominis Plane Block
03

In context

Lead sponsor

Adiyaman University Research Hospital is the lead sponsor of 48 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • ASA I-II, female, Laparoscopic cholecyctectomy, Subcostal TAP , 18-65 years old patient

Exclusion criteria

Exclusion Criteria:

  • ASA III-IV
  • \<18 , >65 years old patients
  • menstrual disorders
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Group LB

    Patients that undergoing subcostal TAP block identified as being in the luteal phase by inquiring about the date of their last menstrual period.

    Other: Subcostal Transversus Abdominis Plane Block

  • Experimental
    Group FB

    Patients that undergoing subcostal TAP block identified as being in the follicular phase by inquiring about the date of their last menstrual period.

    Other: Subcostal Transversus Abdominis Plane Block

  • No intervention
    Group L

    Patients identified as being in the luteal phase by inquiring about the date of their last menstrual period.

  • No intervention
    Group F

    Patients identified as being in the follicular phase by inquiring about the date of their last menstrual period.

Interventions

  • OtherSubcostal Transversus Abdominis Plane Block

    After ensuring airway safety under general anesthesia, a bilateral Transversus Abdominis Plane Block using 20 cc of 0.25% bupivacaine with a subcostal approach under ultrasound guidance will be administered

06

What researchers measure

Primary outcomes

  1. visual analogue scale (VAS)

    The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain."

    Time frame: postoperative 1st,2nd, 6.- 12.-24. hour

Secondary outcomes

  1. Quality of Recovery - 15

    The QoR-15 scale is a unidimensional measurement of quality of recovery measured in five domains: physical comfort, pain, physical independence, psychological support, and emotional state. The QoR-15 scale provides a score ranging from 0 to 150, with a high score indicating a good quality of recovery

    Time frame: postoperative 24. hour

07

Study locations

1 site
  • Adıyaman Training and Research Hospital
    Adıyaman, 02200, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 14, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06566365
Lead sponsor
Adiyaman University Research Hospital
Responsible party
Nezir Yılmaz (MD, Adiyaman University Research Hospital) — Principal investigator
First posted
Aug 22, 2024
Start date
Nov 15, 2024 (estimated)
Primary completion
Dec 30, 2024 (estimated)
Completion
Dec 31, 2024 (estimated)
Last update
Nov 14, 2024

Study contacts

Nezir YILMAZ, MD
Contact
yilmaznezir@hotmail.com
+90 5068939496

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion